Associated Papers
EGFR inhibition augments the therapeutic efficacy of the NAT10 inhibitor Remodelin in Colorectal cancer.
Zheng Y et al.
Journal of Experimental & Clinical Cancer Research : Cr, 2025
Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner.
Liao L et al.
Cell Research, 2023
Recent Advances on the Structure and Function of RNA Acetyltransferase Kre33/NAT10.
Sleiman S et al.
Cells, 2019
Select a paper to view details